Skip to main content

Almudena Sanchez Garcia

Institutions of which they are part

Predoctoral researcher
Biomedical Research in Cancer Stem Cells
Vall Hebron Institut de Recerca

Almudena Sanchez Garcia

Institutions of which they are part

Predoctoral researcher
Biomedical Research in Cancer Stem Cells
Vall Hebron Institut de Recerca

Projects

New compounds targeting head and neck cancer as Trojan horses against chemoresistant cells

IP: Matilde Lleonart Pajarin
Collaborators: Yoelsis Garcia Mayea, Marina Bataller Fernández, Gabriela Isabel Fuentes Llopis, Almudena Sanchez Garcia
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 20000
Reference: 2023 LLAV 00102
Duration: 01/02/2024 - 31/07/2024

Therapeutical approaches against chemoresistant cancers

IP: Matilde Lleonart Pajarin
Collaborators: Yoelsis Garcia Mayea, Fco. Xavier De la Cruz Montserrat, Juan Lorente Guerrero, Natalia Padilla Sirera, Marina Bataller Fernández, Almudena Sanchez Garcia, Selen Ozkan
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 0.01
Reference: 2021 SGR 01205
Duration: 01/01/2022 - 30/06/2025

Novel terapéutic approaches against COVID-19

IP: Matilde Lleonart Pajarin
Collaborators: Marina Bataller Fernández, Almudena Sanchez Garcia, Yoelsis Garcia Mayea
Funding agency: Fundació La Marató de TV3
Funding: 161875
Reference: 202116
Duration: 23/09/2021 - 22/09/2024

Drug-screen against novel proteins involved in cancer resistance

IP: Matilde Lleonart Pajarin
Collaborators: Almudena Sanchez Garcia, Miriam Izquierdo Sans
Funding agency: Fundació Institut de Recerca HUVH
Funding: 50649.27
Reference: VHIR/BEQUESPREDOC/2019/SANCHEZ
Duration: 14/09/2020 - 13/09/2023

Related news

On World Cancer Research Day, we highlight the oncology research model of the Vall d'Hebron Campus that allows laboratory results to be transferred as quickly as possible to clinical practice.

Vall d’Hebron ha celebrat avui la Jornada del Dia Mundial contra el Càncer, una malaltia cada cop més freqüent que patiran al llarg de la vida un de cada dos homes i una de cada tres dones del nostre entorn.

The work has compared sensitive and resistant cells to cisplatin treatment to understand the mechanisms involved in resistance and to find new biomarkers and therapies.

Related professionals

Melek Denizli

Melek Denizli

Research technician
Biomedical Research in Gynaecology
Read more
Julian Brandariz

Julian Brandariz

Research technician
Read more
Karla patricia Rojas Cuotto

Karla patricia Rojas Cuotto

Predoctoral researcher
Research Group of Physical Medicine and Rehabilitation
Read more
Elisa Carenza

Elisa Carenza

Predoctoral researcher
Neurovascular Diseases
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.